Keynote Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$510K	Buy	1,145 +40	+4%	+$17.8K	0.34%	80
2025 Q1	$536K	Buy	1,105 +20	+2%	+$9.7K	0.38%	70
2024 Q4	$437K	Buy	1,085 +15	+1%	+$6.04K	0.34%	81
2024 Q3	$498K	Buy	+1,070	New	+$498K	0.38%	76